Advertisement

Topics

Endo Pharmaceuticals Inc. Company Profile

11:00 EST 21st November 2017 | BioPortfolio


News Articles [587 Associated News Articles listed on BioPortfolio]

Endo Pharmaceuticals to remove OPANA from the market

Endo International plc continues to believe in the safety, efficacy, and favorable benefit-risk profile of OPANA® ER (oxymorphone hydrochloride extended release) when used as intended, and notes tha...

Alexza Pharmaceuticals (ALXA) and Endo International plc - (ENDP) Head to Head Comparison

Alexza Pharmaceuticals and Endo International plc - are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitabi...

Endo Acquisition, PTV News: May 07, 2010

Endo Pharmaceuticals to buy HealthTronics in US $223M deal

Endo gives way and withdraws opioid painkiller after FDA pressure

Endo Pharmaceuticals has announced it will remove its Opana ER opioid painkiller from the US market, a month after the FDA requested because of the potential for abuse. Dublin-based Endo said that it...

Endo Files Federal Lawsuit to Obtain FDA Compliance with Drug Quality and Security Act of 2013

DUBLIN, Oct. 26, 2017 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Sterile Products, LLC and Endo Par Innovation Company, LLC, filed suit in the ...

Endo withdraws product as FDA secures step in opioid crisis fightback

The FDA took the unusual step to ask Endo Pharmaceutical to voluntarily withdraw its opioid painkiller, Opana ER, from the market one month ago. It was the first time that the agency had recommended s...

Endo International acquires Par Pharmaceutical

Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, includin...

Beshear announces effort to combat opioid overdoses Read Story AP

Kentucky's Democratic attorney general has sued a pharmaceutical company he says directly contributed to more than 190 opioid overdose deaths in the state. Andy Beshear filed a lawsuit Monday agai...

Drugs and Medications [287 Associated Drugs and Medications listed on BioPortfolio]

Losartan potassium [Endo Pharmaceuticals Inc. DBA Endo Generic Products]

Losartan Potassium Tablets USP R only

Pramipexole dihydrochloride [Endo Pharmaceuticals Inc. DBA Endo Generic Products]

Pramipexole Dihydrochloride Tablets 0.125 mg, 0.25 mg, 0.5 mg, 1 mg, and 1.5 mg Tablets Rx only Prescribing Information

Antitussivehycodan(hydrocodone bitartrate and homatropine methylbromide)tablets and syrupciiir only [Endo Pharmaceuticals Inc.]

ANTITUSSIVEHYCODAN(Hydrocodone Bitartrate and Homatropine Methylbromide)TABLETS AND SYRUPCIIIR only

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Opana [Endo Pharmaceuticals, Inc]

ENDO PHARMACEUTICALS 003466/September 2006 OPANA (Oxymorphone Hydrochloride) INJECTION 1mg/mL CII Opioid Analgesic Rx only

PubMed Articles [207 Associated PubMed Articles listed on BioPortfolio]

Effectiveness of XP-endo Finisher and XP-endo Finisher R in removing root filling remnants: a micro-CT study.

To evaluate the efficacy of filling material removal from oval-shaped canals after the use of supplementary files (XP-endo Finisher and XP-endo Finisher R) through micro-computed tomographic (micro-CT...

Endo-lysosomal dysfunction: a converging mechanism in neurodegenerative diseases.

Endo-lysosomal pathways are essential in maintaining protein homeostasis in the cell. Numerous genes in the endo-lysosomal pathways have been found to associate with neurodegenerative diseases, includ...

On the Threading of an Inherently Directional Calixarene Wheel with Oriented Ammonium Axles.

The threading of mono-stoppered alkylbenzylammonium axles 7+ and 8+ with the calix[6]-wheel 3 can occurs by both the routes of entering of the macrocycle 3 in the cone conformation: through-the-exo-ri...

Synthesis of Cis,syndiotactic-A-alt-B Copolymers from Enantiomerically Pure Endo-2-Substituted-5,6-Norbornenes.

Cis,syndiotactic A-alt-B copolymers, where A and B are two enantiomerically pure endo-2-substituted-5,6-norbornenes with "opposite" chiralities of the endo-2-substituted-5,6-norbornene skeleton, can b...

Endo-α-mannosidase Catalyzed Transglycosylation.

In order for facilitating the synthesis of oligosaccharides, transglycosylation reactions mediated by glycoside hydrolases have been studied in various contexts. In this study, we examined transglycos...

Clinical Trials [260 Associated Clinical Trials listed on BioPortfolio]

Pharmacokinetics of Lidocaine in Healthy Adults

The study to be performed will utilize already FDA-approved marketed products in healthy adults for the purpose to generate data for establishing rate of drug delivery of Lidoderm® topica...

The ValenTx Endo Bypass System in Obese Subjects

The purpose of this study is to collect clinical data to support the use of the ValenTx Endo Bypass System to improve weight loss and the resolution of comorbidities in obese subjects.

Comparing Between XP Endo Finisher and Conventional Irrigation Method On Post-Operative Flare Ups In Necrotic Teeth

Comparing the postoperative flare ups and pain after adding the XP Endo Finisher to the final irrigation protocol on necrotic mandibular premolars.

Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening

The study evaluates whether the use of a novel endoscopic cap (the endo-cuff) at the tip of a colonoscope improves the numbers of polyps detected during bowel cancer screening colonoscopy....

Endo-Laparoscopic Approach Versus Conventional Open Surgery in Obstructing Left-Sided Colon Cancer: RCT

Objective: Whether temporary endoscopic decompression by Self-expanding metal stents (SEMS) could allow these patients to undergo successful laparoscopic resection (endo-laparoscopic appro...

Companies [1293 Associated Companies listed on BioPortfolio]

Endo Pharmaceuticals

Endo Pharmaceuticals are a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.

Endo Pharmaceuticals Inc.

Endo Pharmaceuticals Holdings Inc.

Endo Pharmaceuticals Solutions Inc.

Endo Pharmaceuticals Holdings

More Information about "Endo Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Endo Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Endo Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Endo Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endo Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Endo Pharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record